Palatin Technologies, Inc. Issued U.S. Patent for Key Component in PL-3994 … – DigitalJournal.com (press release)

Palatin Technologies, Inc. Issued U.S. Patent for Key Component in PL-3994
DigitalJournal.com (press release)
A small molecule mimic claimed in the issued patent is used in making PL-3994, Palatin's lead peptide mimetic natriuretic peptide receptor A agonist, which is in development for treatment of acute exacerbations of asthma, heart failure and refractory

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.